RxBiologics
Bhindu Ravi is an accomplished scientist with extensive experience in the biotechnology and cancer research fields. Currently serving as a Team Leader and Senior Scientist at RxBiologics since February 2021, Bhindu previously held multiple roles, including Senior Scientist and Biological Safety Officer at Crescendo Biologics Limited from September 2016 to February 2021, and Research Scientist at Scotia Biologics Limited from April 2009 to September 2012. Bhindu's academic background includes a Ph.D. in Comparative Oncology from The University of Edinburgh and an MSc in Medical Biotechnology with Biobusiness from the University of Aberdeen. Notable research includes investigating hsp90 inhibitor drugs in cancer therapy and participating in the development of the Life Marker Chip for the ExoMars mission.
This person is not in any teams
RxBiologics
RxBiologics offers antibody discovery services using our proprietary Galaxy® library platform to generate world-class biologics with optimal drug development qualities. We make biologics drug discovery accessible to anyone with a great idea. Along with our parent company, RxCelerate, we support your biologics R&D from early discovery through pre-clinical phases. At RxBiologics, we work with you to design bespoke programmes with optimised workflows for accelerated progression to clinic.